Heart drug cuts prostate cancer risk; holds potential for therapeutic use
Links shared publicly online about this topic.
- 469total visits
Heart drug cuts prostate cancer risk; holds potential for therapeutic use
Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, had a 24 percent lower risk for prostate cancer. The scientists say further research about the discovery may lead to use of the drug, or new ones that work the same ...
View full resource at physorg.com
Most Recently Shared on April 3, 2011 at 10:34 am By:
Heart drug cuts prostate cancer risk; holds potential for therapeutic use: Johns Hopkins scientists and their co... http://bit.ly/efz9q9
Advertisement
